Coryfin 2, 8 mg + 16, 8 mg 24 tablets

Coryfin 2.8 mg + 16.8 mg 24 tablets is an over-the-counter medicine specifically formulated for the symptomatic treatment of cough and hoarseness . Thanks to its composition based on menthol ethyl glycolate and sodium ascorbate (equivalent to 15 mg of vitamin C per tablet), Coryfin acts quickly to relieve throat irritation and reduce phlegm , proving particularly useful also for those who suffer from voice alterations or for smokers who need effective relief.

Coryfin lozenges are characterized by a pleasant and refreshing lemon flavor , making the treatment of dry cough and productive cough more pleasant. Each lozenge contains glucose and sucrose , in addition to selected flavors to guarantee an immediate and long-lasting relief experience. Coryfin is indicated for those looking for a practical and fast solution to relieve the symptoms of a sore throat , both in the case of a cold and vocal fatigue.

Thanks to its effectiveness, Coryfin 2.8 mg + 16.8 mg 24 tablets is an ideal choice for those who want to quickly reduce throat discomfort and promote respiratory tract well-being, both at home and away. The 24-tablet pack is perfect for always having a reliable remedy against throat disorders.

ACTIVE INGREDIENTS

Active ingredients contained in Coryfin 2.8 mg + 16.8 mg 24 tablets - What is the active ingredient in Coryfin 2.8 mg + 16.8 mg 24 tablets?

Coryfin 6.5 mg + 18 mg lozenges Active ingredients : menthol ethyl glycolate 6.5 mg; sodium ascorbate 18.0 mg equivalent to 16 mg of ascorbic acid (Vitamin C). Excipients with known effects : glucose 0.9 g, sucrose 1.1 g. Coryfin 2.8 mg + 16.8 mg lozenges Active ingredients : menthol ethyl glycolate 2.8 mg; sodium ascorbate 16.8 mg equivalent to 15 mg of ascorbic acid (Vitamin C). Excipients with known effects : glucose 0.9 g, sucrose 1.1 g. Coryfin 6.5 mg + 112.5 mg lozenges Active ingredients : menthol ethyl glycolate 6.5 mg; sodium ascorbate 112.5 mg equivalent to 100 mg of ascorbic acid (Vitamin C). Excipients with known effect : glucose 0.8 g, sucrose 1 g. For the full list of excipients, see section 6.1.

EXCIPIENTS

Composition of Coryfin 2.8 mg + 16.8 mg 24 tablets - What does Coryfin 2.8 mg + 16.8 mg 24 tablets contain?

One tablet of Coryfin 6.5 mg + 18 mg contains: menthol-eucalyptol flavour, citric acid, sucrose , glucose . One tablet of Coryfin 2.8 mg + 16.8 mg contains: menthol, citric acid, lemon essence, sucrose , glucose . One tablet of Coryfin 6.5 mg + 112.5 mg contains: menthol, mandarin flavour, citric acid, sucrose , glucose .

DIRECTIONS

Therapeutic indications Coryfin 2.8 mg + 16.8 mg 24 tablets - Why is Coryfin 2.8 mg + 16.8 mg 24 tablets used? What is it used for?

Symptomatic in the treatment of cough and hoarseness. Coryfin relieves local irritation and reduces catarrh, even in smokers.

CONTRAINDICATIONS AND SIDE EFFECTS

Contraindications Coryfin 2.8 mg + 16.8 mg 24 tablets - When should Coryfin 2.8 mg + 16.8 mg 24 tablets not be used?

– Hypersensitivity to the active substances or to any of the excipients listed in section 6.1. – Children up to 30 months of age. – Children with a history of epilepsy or febrile convulsions.

DOSAGE

Quantity and method of taking Coryfin 2.8 mg + 16.8 mg 24 tablets - How to take Coryfin 2.8 mg + 16.8 mg 24 tablets?

Dosage Coryfin 6.5 mg + 18 mg and Coryfin 2.8 mg + 16.8 mg: One tablet every 1–2 hours, up to a maximum of 8 tablets per day. Coryfin 6.5 mg + 112.5 mg: One tablet every 2–3 hours, up to a maximum of 6 tablets per day. Paediatric population In children over 30 months, halved doses. Do not exceed the indicated doses. The duration of treatment should not exceed 3 days.

CONSERVATION

Storage Coryfin 2.8 mg + 16.8 mg 24 tablets - How to store Coryfin 2.8 mg + 16.8 mg 24 tablets?

This medicinal product does not require any special storage conditions.

WARNINGS

Warnings Coryfin 2.8 mg + 16.8 mg 24 tablets - About Coryfin 2.8 mg + 16.8 mg 24 tablets it is important to know that:

This product contains terpene derivatives which, in excessive doses, can cause neurological disorders such as convulsions in infants and children. Treatment should not be prolonged for more than 3 days due to the risks associated with the accumulation of terpene derivatives, such as camphor, cineole, niaouli, wild thyme, terpineol, terpin, citral, menthol and essential oils of pine needles, eucalyptus and turpentine (due to their lipophilic properties the rate of metabolism and disposal is unknown) in the tissues and brain, in particular neuropsychological disorders. A dose higher than recommended should not be used to avoid a greater risk of adverse reactions to the medicinal product and disorders associated with overdose (see section 4.9). The product is flammable, it should not be brought close to flames. Coryfin contains glucose . Patients with rare problems of glucose-galactose malabsorption should not take this medicine. Coryfin contains sucrose. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase insufficiency should not take this medicine. To be taken into consideration in patients with diabetes mellitus.

INTERACTIONS

Interactions Coryfin 2.8 mg + 16.8 mg 24 tablets - Which medicines or foods can modify the effect of Coryfin 2.8 mg + 16.8 mg 24 tablets?

Coryfin should not be used in conjunction with other products (medicinal or cosmetic) containing terpene derivatives, regardless of the route of administration (oral, rectal, cutaneous, nasal or inhalation).

SIDE EFFECTS

Like all medicines, Coryfin 2.8 mg + 16.8 mg 24 tablets can cause side effects - What are the side effects of Coryfin 2.8 mg + 16.8 mg 24 tablets?

In rare cases of sensitizing or irritating effects, discontinue use and institute appropriate therapy. Paediatric population Due to the presence of menthol and in case of non-compliance with the recommended doses, there may be a risk of convulsions in children and infants. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorisation of the medicinal product is important, as it allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at: www.agenziafarmaco.gov.it/it/responsabili.

OVERDOSE

Overdose Coryfin 2.8 mg + 16.8 mg 24 tablets - What are the risks of Coryfin 2.8 mg + 16.8 mg 24 tablets in case of overdose?

No effects of overdose are known. Paediatric population In case of accidental oral intake or incorrect administration in neonates and children, the risk of neurological disorders may occur. If necessary, administer appropriate symptomatic treatment in specialized care centers.

PREGNANCY AND BREASTFEEDING

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Coryfin 2.8 mg + 16.8 mg 24 tablets.

Pregnancy There are no or limited amount of data from the use of menthol in pregnant women. Coryfin is not recommended during pregnancy and in women of childbearing potential not using contraceptive measures. Breastfeeding There is insufficient information on the excretion of menthol in human milk. Coryfin should not be used during breastfeeding.

DRIVING AND USE OF MACHINERY

Taking Coryfin 2.8 mg + 16.8 mg 24 tablets before driving or using machines - Does Coryfin 2.8 mg + 16.8 mg 24 tablets affect driving or using machines?

This medicine does not affect the ability to drive or use machines.